Aethlon Medical to merge with North Immunology; ~$180M financing
Aethlon Medical entered a definitive all-stock merger with North Immunology and an oversubscribed private placement of about $180M, expected to fund operations into 2H 2028. Pre-merger Aethlon holders are expected to own about 4.75% of the combined company.